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Treatment with the natural chemical sulforaphane (SF) ameliorates skin blistering in keratin 14 (K14)-deﬁcient mice,
correlating with the induction of K16 and K17 in the basal layer of epidermis (Kerns et al., PNAS 104:14460, 2007). Here
we address the basis for the SF-mediated K16 and K17 induction in mouse epidermis in vivo. As expected, induction of
K16 partly depends on the transcription factor Nrf2, which is activated by SF exposure. Strikingly, K17 induction occurs
independently of Nrf2 activity and parallels the decrease in glutathione occurring shortly after epidermal exposure to SF.
Pharmacological manipulation of glutathione levels in mouse epidermis in vivo alters K17 and K16 expression in the
expected manner. We present ﬁndings suggesting that select MAP kinases participate in mediating the Nrf2- and
glutathione-dependent alterations in K16 and K17 levels in SF-treated epidermis. These ﬁndings advance our under-
standing of the effect of SF on gene expression in epidermis, point to a role for glutathione in mediating some of these
effects, and establish that SF induces the expression of two contiguous and highly related genes, K16 and K17, via distinct
mechanisms.
INTRODUCTION
Diets rich in cruciferous vegetables correlate with a reduced
risk of developing various cancers in the human population
(Talalay and Fahey, 2001; Hayes et al., 2008; Zhang et al., 2009).
The general mechanism accounting for this beneﬁt is thought
to involve the inhibition and activation of phase 1 and phase
2 metabolic enzymes, respectively, causing a deactivation
and/or hastened disposal of potential carcinogens (Kobayashi
and Yamamoto, 2006; Myzak and Dashwood, 2006; Tan and
Spivack, 2009). Isolation and identiﬁcation of the isothiocya-
nate sulforaphane (SF) as the chemopreventive agent in a
precursor form, in broccoli sprout extracts (Zhang et al.,
1992) paved the way for the discovery of the Nrf2-Keap1-
ARE pathway of transcriptional regulation, which mediates
these effects at the molecular level (Talalay and Fahey, 2001;
Kobayashi and Yamamoto, 2006). Nrf2, a cap’n’collar bZIP
family transcription factor (Moi et al., 1994), activates gene
expression after binding to antioxidant response elements
(AREs) located in or near the promoter region of its target
genes (McMahon et al., 2001; Wakabayashi et al., 2004). Nrf2
is normally sequestered in the cytoplasm by the cysteine-
rich Keap1 protein, a substrate adaptor protein for a Cul3-
dependent ubiquitin ligase complex that targets Nrf2 for
proteasome-mediated degradation (Zhang and Gordon,
2004). SF and other isothiocyanates allow for Nrf2 trans-
location to the nucleus (and Nrf2-dependent transcrip-
tion) by reacting with thiol groups in Keap1, inactivating
it (Dinkova-Kostova et al., 2002). The full extent of the
transcriptional program regulated by SF or Nrf2-Keap1-ARE
and its biological implications and therapeutic potential ap-
pear underestimated at present.
We reported that treatment with SF markedly reduces the
skin blistering and morbidity associated with a keratin 14
(K14) deﬁciency in neonatal mice (Kerns et al., 2007). Nor-
mally, K14 copolymerizes with its obligatory partner protein
K5 to yield 10-nm intermediate ﬁlaments that, once orga-
nized into a pan-cytoplasmic network, provide crucial struc-
tural support in basal keratinocytes of epidermis and related
stratiﬁed epithelia (Coulombe et al., 2009). Partial or com-
plete loss of either K5 or K14 function (e.g., through null
mutations or dominantly acting missense alleles) renders
basal keratinocytes fragile and accounts for epidermolysis
bullosa simplex, a rare inherited bullous disease in which
the basal layer of epidermis, and occasionally related surface
epithelia, rupture readily in response to trivial mechanical
trauma (Fine et al., 2008; Coulombe et al., 2009). The beneﬁt
afforded by SF treatment in K14 null neonatal mice likely
involves the induction of K16 and K17, two keratins highly
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4068related to K14 both in primary structure and properties
(Kerns et al., 2007). In this setting, K16 and especially K17 are
thought to act as surrogate keratins which, owing to their
ability to copolymerize efﬁciently with partner K5, compen-
sate for the loss of K14 protein (Kerns et al., 2007; Coulombe
et al., 2009).
Broccoli sprout extracts rich in SF, the natural product
form in which known amounts of the latter can be safely
delivered to humans (Shapiro et al., 2006; Cornblatt et al.,
2007), represents a form of therapy worth considering for
epidermolysis bullosa simplex and related conditions (Kerns
et al., 2007; Coulombe et al., 2009). Several issues must be
addressed in preparation for clinical trials testing this idea.
Here, we investigate the mechanisms that account for the
induction of K16 and K17 expression in mouse skin keratin-
ocytes treated with SF in vivo.
MATERIALS AND METHODS
Animals, Antibodies, and Chemicals
Studies involving mice were approved by the Johns Hopkins University
Institutional Animal Care and Use Committee. SKH-1 hairless mice were
purchased (Charles River Laboratories, Wilmington, MA). Nrf2/ and hy-
pomorphic Keap1 mice were maintained as described (Chan et al., 1996;
Osburn et al., 2008). Antibodies used included rabbit polyclonals against K6,
K16, and K17 (P.A.C. laboratory) and a mouse monoclonal anti-actin (Sigma,
St. Louis, MO). Fluorochrome-conjugated goat anti-rabbit antibodies were
from Kirkegaard & Perry Laboratories (Gaithersburg, MD). SF [1-isothiocya-
nato-4(R,S)-(methylsulﬁnyl)butane] was obtained from LKT Laboratories (St.
Paul, MN). Solutions of SF in jojoba oil (MP Biomedicals, Solon, OH) were
prepared on the day of application. Glutathione monoethyl ester, c-Jun N-
terminal kinase (JNK) II inhibitor SP60015, p38 inhibitor SB202190, and ex-
tracellular signal–regulated kinase (ERK)1/2 inhibitor UO126 were from Cal-
biochem (San Diego, CA). Mitogen-activated protein (MAP) kinase inhibitors
were diluted in 1:250 acetone:oil and made fresh before each application.
l-Buthionine-sulfoximine was from Sigma (St. Louis, MO).
Mouse Studies
Seven-week-old female Nrf2/ SKH-1 hairless were topically treated with 1
mol SF in 100 l jojoba oil once a day for 4 d and killed on day 5. For keratin
expression studies mice were treated four times, 48 h apart, and killed 24 h
after the last treatment. Neonatal Nrf2/ mice in the C57BL/6 background
were treated with 1 mol of SF in 100 l jojoba oil daily on postnatal day 5
(P5), P6, and P7 and killed on P8, and their dorsal skin was harvested for
study. Seven-week-old SKH-1 female hairless mice were given four i.p. injec-
tions of either 50 mol l-buthionine-sulfoximine (BSO) in 100 l jojoba oil or
5 mol glutathione monoethyl ester (GME) in 100 l jojoba oil, whereas a
subset received a topical treatment of 1 mol SF in 100 l jojoba oil on the
second, third, and fourth day. On the ﬁfth day dorsal skin was harvested for
analysis. Seven-week-old female SKH-1 hairless mice and Nrf2/ SKH-1
hairless mice were treated with 10 M SB20219, 100 M SP600125, 100 M
UO126, or vehicle control (100 l of acetone:oil 1:250) 30 min before and 30
min after topical treatment with 1 mol SF in 100 l jojoba oil daily for2da n d
were killed on day 3. Five-week-old female hypomorphic Keap1 C57BL/6
mice were killed, and tissue was analyzed as described.
Biochemical Analyses
RNA was extracted from full-thickness skin of wild-type C57BL/6 and hy-
pomorphic Keap1 C57BL/6 mice using TRIzol according to the manufacturer’s
instructions (Invitrogen, Carlsbad, CA). After DNAse treatment (RNase free
DNase kit; Qiagen, Valencia, CA), 1 g of total RNA from each phenotype
was reverse-transcribed (Advantage RT-for PCR kit; Clontech, Mountain
View, CA). First-strand cDNA was used for PCR analysis of gene expression
using Invitrogen Taq. Target mRNAs and oligonucleotide primer sets are
described in Kerns et al. (2007). Intensity of electrophoresed, ethidium bro-
mide–stained PCR products was quantiﬁed using the NIH ImageJ freeware
(http://rsb.info.nih.gov/ij/). For protein analysis, dorsal skin was harvested
from control and treated Nrf2/ SKH-1 hairless mice, and total protein was
extracted (Paladini and Coulombe, 1999). Protein concentrations were ob-
tained by using a Bradford Assay Kit (Bio-Rad, Hercules, CA). Equal amounts
of protein (10–20 g) were resolved on 8.5% SDS/PAGE gels and blotted onto
nitrocellulose. Bound primary antibodies were detected via enhanced chemi-
luminescence (Amersham Pharmacia Biotech, Pittsburgh, PA). For total glu-
tathione measurements, full-thickness dorsal skin was ﬂash-frozen in liquid
nitrogen and pulverized into a ﬁne powder. A total of 10 volumes of 5%
5-sulfosalicylic acid solution was added to 0.1–0.3 g of tissue powder. Sam-
ples were then homogenized with 3 ml PTFE pestle in glass tube, stored at 4°C
for 10 min, and then centrifuged at 10,000  g at 4°C for 10 min to remove the
denatured protein precipitate. The samples were analyzed using a commer-
cial kit (Sigma) based on the original method of Sedlak and Lindsay (1968), a
kinetic assay in which GSH (reduced glutathione) continuously reduces 5,5-
dithiobis(2-nitrobenzoic acid) (DTNB) to 5-thio-2-nitrobenzoic acid (TNB),
and the resulting GSSG (oxidized glutathione) is recycled by glutathione
reductase and NADPH. TNB was spectrophotometrically measured at 412
nm. The levels of total and phosphorylated MAP kinases and their targets
were analyzed using a commercial Sandwich ELISA kit from Cell Signaling
(St. Louis, MO).
Morphological Analyses
Five-micrometer sections were obtained from surgically harvested back skin
tissue samples, embedded, and frozen in OCT (Sakura, Torrance, CA). For
indirect immunoﬂuorescence, they were thawed, postﬁxed with neutral
buffer Formalin for 10 min at room temperature, and incubated with primary
antibodies to K17, K16, and K6. Bound primary antibodies were revealed by
incubation with FITC-conjugated secondary antibodies (Kirkegaard & Perry
Laboratories). The samples were also stained with Hoechst (Sigma) stain
following the manufacturer’s instructions.
Quantitation of Immunoﬂuorescence
Micrographs were recorded using a Zeiss AxioPlan2 upright microscope
equipped with a Zeiss HRC high-resolution digital camera (Thornwood, NY).
Control and experimental skin samples were examined consecutively, and
micrographs of stained preparations were recorded using the same exposure
conditions. Immunoﬂuorescence intensity was determined by measuring the
mean pixel density of immunoﬂuorescence in three 25-m2 areas of epidermis
per stained preparation of skin tissue, using Zeiss’ Axiovision software. Each
section selected was representative of its experimental group, and the 25-m2
areas were selected from predetermined sites of epidermis (center, left, and
right of the section) to foster unbiased sampling.
Statistical Analyses
Results were expressed as means  SEM. The Student’s t test was used for
comparison between groups. p  0.05 was considered statistically signiﬁcant.
RESULTS
Nrf2 Plays a Partial Role in Keratin Regulation by SF in
Skin Epidermis
The Nrf2-Keap-ARE pathway represents the best character-
ized mechanism to account for the SF-dependent transcrip-
tional induction of speciﬁc genes (Talalay and Fahey, 2001;
Kobayashi and Yamamoto, 2006). Several AREs matching
the consensus for Nrf2 binding can be found in the area of
the mouse and human genome that houses the clustered and
highly conserved K14, K16, and K17 genes (data not shown).
Recent studies have shown that K6, a polymerization part-
ner for K16/K17 in vivo (McGowan and Coulombe, 1998b),
and K16 are bona ﬁde Nrf2 target genes (Wakabayashi et al.,
2003; Endo et al., 2008). To examine the role of the Nrf2-
Keap-ARE pathway in SF-mediated induction of K16 and
K17 expression in the epidermis, studies were conducted in
a mouse strain carrying a Nrf2 null mutation (Wakabayashi
et al., 2003), and another one in which Nrf2-dependent tran-
scription is enhanced secondary to a Keap1 hypomorph allele
(Osburn et al., 2008). The Nrf2 null allele was transferred to
the SKH-1 hairless strain (which is euthymic and immuno-
competent; Benavides et al., 2009) to augment the ease and
consistency of SF topical delivery. A dosage of 1 mol SF,
applied to the middorsum of mice, was used throughout this
study because it rescues the skin fragility characteristic of
K14 null mouse skin without signiﬁcantly impacting prolif-
eration or apoptosis in vivo (Kerns et al., 2007). Because K16
and especially K17 are robustly expressed in hair follicles
under normal conditions, whereas the epidermis represents
the exclusive interest of our study, the primary mean of
sample analysis used was indirect immunoﬂuorescence us-
ing well-characterized primary antibodies coupled with
software-based ﬂuorescence quantitation (see Materials and
Methods).
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treated with 1 mol SF consistently showed a signiﬁcant
increase of K17 and K16 immunoreactivity in the epidermis
(Figure 1, A and B; see Supplemental Table S1a for numer-
ical data and p values) and Western blotting (Figure 1E). A
minimal impact was seen on K6 expression (Figure 1, A and
B). The epidermis of SF-treated Nrf2 null mice in the SKH-1
background was thicker than in controls. Epidermal thick-
ening was previously observed after chronic SF treatment of
SKH-1 hairless mice (Kerns et al., 2007). A similar change in
keratin expression was observed after SF treatment of Nrf2
null pups in the C57BL6 strain background (e.g., Figure 1, C
and D; Supplemental Table S1b), indicating that this out-
come was not a function of the genetic background.
We examined the mRNA levels for select genes in back-
skin tissue of adult C57BL6 mice carrying a hypomorphic
Keap1 allele. Previous studies of these mice showed en-
hanced Nrf2-dependent transcription in several tissues (Os-
burn et al., 2008). Relative to wild type, Keap1 mRNA levels
were reduced to 60% in Keap1 mutant skin, after normal-
ization to HPRT (hypoxanthine phosphoribosyltransferase)
levels (Supplementary Figure S1A). K16 and K6 mRNAs
were elevated 2.1- and 1.4-fold, respectively, in Keap1
mutant skin. K17 mRNA, in contrast, remained unaltered,
whereas the K14 mRNA was slightly decreased (Supple-
mental Figure S1A). An increase in K6 and K16 immunore-
activity, but not K17, was detected in Keap1 mutant epider-
mis (Supplemental Figure S1B). The ﬁndings garnered from
Nrf2 null and Keap1 mutant mice suggest that the induction
of K16 in SF-exposed epidermal keratinocytes proceeds
through Nrf2-dependent and -independent mechanisms,
whereas K17 induction occurs independently from Nrf2.
Although not a primary concern in this study, the issue of
how the type I-to-type II keratin ratio is maintained after SF
treatment is of interest. Preliminary studies revealed modest
increases in the steady-state levels of K5 and K1, but no
change in K6 antigens, in extracts prepared from SF-treated
skin (data not shown). Follow-up studies are required to
address this issue in full.
Correlation of Glutathione Levels and Induction of
Keratins by SF in Skin Epidermis
In cultured hepatocytes, SF directly conjugates with GSH, an
antioxidant with a critical role in the cellular response to
stress, resulting in lowered GSH levels 30 min after treat-
ment (Zhang, 2000), and a subsequent elevation of GSH
levels 24 h after treatment (Ye and Zhang, 2001). Similar
ﬁndings were recently reported in SF-treated mouse embry-
onic ﬁbroblasts (Higgins et al., 2009). We tested whether SF
impacts glutathione levels in a similar manner in mouse skin
tissue. Total glutathione levels were measured at 1.5, 2, 5.5,
and 24 h after topical treatment of SKH-1 hairless mice with
1 mol SF or vehicle. There was no signiﬁcant change in
glutathione levels at 1.5 h after SF treatment. At 2 h, gluta-
thione levels had fallen to 53  11% of those seen in control-
treated skin. This was followed by a rise in glutathione
levels to 117  17 and 121  06% of controls by 5.5 and 24 h,
respectively (Figure 2A; see Supplemental Table S2a for
absolute values and statistics).
Next, we tested whether the modulation of glutathione
levels impacts K16 and K17 expression in mouse skin epi-
dermis. Female SKH-1 hairless mice were treated systemi-
cally (see Materials and Methods) with BSO, an inhibitor of
glutathione synthesis, or GME, a form of glutathione readily
taken up by cells. Total glutathione levels were measured in
skin samples. Systemic treatment with BSO of SKH-1 hair-
less mice lowered glutathione levels in the backskin to 51 
4% of vehicle-treated control (Figure 2B; Supplemental Table
S2b) and was associated with a signiﬁcant increase in K17
and a smaller, but statistically signiﬁcant increase in K16
Figure 1. Nrf2-independent modulation of keratin expression in skin topically treated with SF. (A) Indirect immunoﬂuorescence for K6,
K16, and K17 (as indicated in the top left corner) in frozen sections prepared from adult SKH-1/Nrf2/ mouse skin treated either with
vehicle (Cont, control) or SF. Sections were lightly stained with Hoechst dye to reveal nuclei. Arrows depict the dermo-epidermal interface.
Epi, epidermis; hf, hair follicle. Bar, 100 m. (B) Quantiﬁcation of fold-change in immunoﬂuorescence signal in the epidermis of SF-treated
adult SKH-1/Nrf2/ mice, relative to treated controls (see A). (C) Quantiﬁcation of fold-change in immunoﬂuorescence signal in the
epidermis of Nrf2/ mice in the C57/Bl6 background, relative to treated controls (see D). (D) Pattern of keratin expression in 8-d-old control
and SF-treated Nrf2/ mice in the C57/Bl6 background. Bar, 100 m. (E) Western immunoblots depicting levels of K16 and 17 antigens
(proteins) in response to control or SF treatment of adult Nrf2/ mice. Actin was used as a loading control. Student’s t test: *p  0.05,
**p  0.01, ***p  0.001.
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and E; Supplemental Table S1c). Likewise, systemic treat-
ment with GME signiﬁcantly raised glutathione levels in the
backskin of SKH-1 hairless mice to 167  7% relative to
vehicle-treated control (Figure 2C; Supplemental Table S2c).
The epidermis of the GME-treated mice was immunoreactive
for K16 but showed no K17 signal beyond hair follicles (Figure
2, D and F; Supplemental Table S1c), where K17 is constitu-
tively expressed (McGowan and Coulombe, 1998a,b).
Systemic treatment with GME partially prevented the de-
crease in glutathione levels 2 h after treatment of skin tissue
with SF, creating an opportunity to assess whether this drop
plays a role in K17 and/or K16 induction. Glutathione levels
in dorsal skin of SKH-1 mice treated with both GME and SF
is 83  6% of vehicle-treated mice, compared with 50  11%
when treated with SF alone (Figure 3A; Supplemental Table
S2d). Remarkably, no induction of K17 was observed in the
epidermis of mice treated with both SF and GME (Figure 3B;
Supplemental Figure S2A and Supplemental Table S1d). In
contrast, the induction of K16 was unaltered in this context
(Figure 3B). Next we wanted to test whether the SF-medi-
ated induction of K16 treatment shows a dependency on the
late-onset rise in the glutathione levels, in the absence of
Nrf2. In SKH-1 null mice, systemic treatment of SKH-1 mice
with BSO partly prevents the rise in glutathione levels 24 h
after SF treatment. Glutathione levels were 74  1% of
vehicle-treatment, compared with 121  6% seen with SF
treatment alone, in such mice (Figure 3C; Supplemental
Table S2e). When examined in Nrf2/ SKH-1 mouse epi-
dermis, induction of K16 is markedly attenuated after com-
bined treatment with SF and BSO relative to SF alone (Figure
3D, Supplemental Figure S2B and Supplemental Table S1e).
Together these results suggest that the modulation of total
glutathione levels, in either direction, is poised to play a key
role in the SF-mediated induction of K16 and K17 in skin
tissue.
SF-induced Keratin Expression Involves MAP Kinase
Activation
Previous studies have implicated the MAP kinases p38,
ERK, and JNK in SF-mediated chemoprevention (e.g., Cho et
al., 2005; Hwang et al., 2005; Jo et al., 2007). In addition,
glutathione has been shown to modulate several MAP ki-
nase cascades, including ERK, p38, and JNK (Limon-Pa-
checo et al., 2007). Each of these MAP kinases converge on
AP-1, a transcription factor that regulates the differential
expression of K6 among other keratin genes (Navarro et al.,
1995; Ma et al., 1997), raising the possibility that they could
be involved in the SF-induced, Nrf2-independent expression
of K17 and/or K16. We treated SKH1- mice with 1 mol SF
(or vehicle control) and measured the levels of total and
phosphorylated forms of key MAP kinases using ELISA. At
2 h after SF treatment, the time at which glutathione levels are
decreased (Figure 2A), there were statistically signiﬁcant in-
creases in phospho-p38 (1.2-fold) and phospho-MEK1/2
(2.2-fold), an increase in phospho-SAP/JNK (1.7-fold),
and little if any change in phospho-ERK1/2 (Figure 4A, data
expressed relative to vehicle-treated skin; see Supplemental
Table S3a for corresponding absolute values and p values).
Compared with controls, systemic GME treatment reduced
the activation of phospho-p38 (by 45%) and phospho-
MEK1/2 (by 56%) at 2 h after SF treatment (Figure 4A;
Supplemental Table S3a). At 24 h after SF treatment, a time at
which glutathione levels are slightly above normal (Figure 2A),
the levels of phospho-p38 (0.93-fold), phospho-SAP/JNK
(1.03-fold), phospho-MEK1/2 (1.2-fold), and phospho-
ERK1/2 (0.90-fold) are similar to levels observed of vehicle-
treated mice (Supplemental Table S3b). These ﬁndings suggest
that the transient activation of p38 and MEK1/2 kinases shortly
after skin keratinocyte exposure to SF is partly due to the
depletion in glutathione levels, whereas JNK activation occurs
independent of the glutathione status.
Figure 2. Role of glutathione in SF-mediated alterations in keratin expression. (A) Time-dependent changes in cellular levels of glutathione
in skin after exposure to SF. Reported data (mean  SEM) are from three independent experiments. (B and C) Modulation of glutathione
levels in the skin of 7-wk-old SKH-1 mice that received four i.p. injections of 50 M BSO or 5 M GME on consecutive days and were
harvested 24 h after the ﬁnal treatment. Data (mean  SEM) are expressed as fold change relative to mice injected with PBS. (D) Indirect
immunoﬂuorescence for keratins 16 and 17 (as indicated in the top left corner) on frozen sections prepared from mice treated with PBS (Cont),
BSO, or GME as described for B and C. Sections were lightly stained with Hoechst dye to reveal nuclei. Arrows depict the dermo-epidermal
interface. Small bright dots are staining artifacts. Epi, epidermis; hf, hair follicle. Bar, 100 m. (E and F) Quantitation of fold-change in
immunoﬂuorescence, relative to control, in the epidermis of 7-wk-old SKH-1 mice after BSO or GME treatment, as described for B and C.
Student’s t test: *p  0.05, **p  0.01, ***p  0.001.
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induction of K17 and K16 by SF, SKH-1 hairless mice were
topically treated with inhibitors of p38 (100 l of SB20219 at
10 M), JNK (100 l of SP600125 at 100 M), or ERK1/2 (100
l of UO126 at 100 M) at 30 min before and 30 min after
topical treatment with 1 mol SF formulated in jojoba oil.
These inhibitors have been used topically in mice by many
other groups (Jaffee et al., 2000; Takanami-Ohnishi et al.,
2002; Bachelor et al., 2005; Lee et al., 2007). An ELISA assay
was used to conﬁrm the effectiveness of treatment with these
inhibitors (Supplemental Figure S3, Supplemental Table
S3c). Signiﬁcantly reduced immunoreactivity for K17 oc-
curred in the epidermis of mice treated with SF and any of
these inhibitors, compared with mice treated with SF alone
(Figure 4B, Supplemental Figure S4A, Supplemental Table
S1f). On the other hand, only UO treatment reduced K16
immunoreactivity that arises after SF treatment (Figure 4B,
Supplemental Figure S4B, Supplemental Table S1f). When
ERK1/2 is inhibited, we ﬁnd that both the Nrf2-dependent
and -independent pathways are both blocked and the SF-
mediated induction of K16 is lost. In the absence of Nrf2
signaling all inhibitor treatments are able to attenuate induc-
tion of K16 gene expression (Figure 4C, Supplemental Figure
S4C, Supplemental Table S1g).
DISCUSSION
The main ﬁndings of our study are as follows. First, we
identify a gene, namely K17, that is induced in an Nrf2-
independent manner in skin epidermis treated with SF. Sec-
ond, we show that SF exposure causes a transient decrease
in total glutathione levels in mouse skin. Such a decrease in
glutathione has been reported for select cell lines in culture
(Zhang et al., 2000; Higgins et al., 2009). Third, we show that
K17 induction closely parallels the drop in glutathione levels
that follows treatment of skin with SF and that this process
also involves the activation of MAP kinases. The latter are
known to converge on AP-1, a transcription factor already
known to participate in the regulation of K6 (Navarro et al.,
1995; Ma et al., 1997) and K16 (Wang and Chang, 2003) in
other biological settings. Fourth, we show that a topical
treatment that reduces glutathione levels induces K17 ex-
pression in mouse epidermis, independently of SF exposure.
Finally, we show that the SF-mediated epidermal induc-
tion of K16 and K17, two neighboring keratin genes that
exhibit a high degree of sequence homology and an over-
lapping regulation (McGowan and Coulombe, 1998b), occurs
through distinct mechanisms in SF-treated keratinocytes (i.e.,
it entails a differential involvement of Nrf2, glutathione, and
MAP kinases).
Our ﬁndings suggest a temporal sequence of molecular
events that ultimately results in the stepwise activation of
select keratin genes in SF-treated epidermis (Figure 5). Early
on (e.g., 3 h; Figure 5A), SF induces K17, coinciding with
the transient drop in glutathione levels and its associated
impact on p38 kinase activity. K17 induction may also in-
volve SF’s ability to activate JNK kinase, which, like other
MAP kinases including p38, can activate AP-1 and (presum-
ably) contribute to activating K17 gene transcription. Later
on (e.g., 24 h; Figure 5B), glutathione levels have re-
bounded, and activated Nrf2 may at this point represent the
main mechanism through which SF impacts gene expression
in epidermal keratinocytes. Activation of Nrf2 could also
result from the MEK-mediated activation of ERK kinase, in
addition to Keap1 inactivation, at this later time (Kang et al.,
2007). Once activated, Nrf2 and AP-1 can each, or tandemly,
activate K16 gene transcription (Figure 5B). This model
could apply to the regulation of additional genes after ex-
posure to SF.
The lack of uniformity with which SF impacts the expres-
sion of K17, K16, and the K6 isoforms in adult mouse epi-
dermis (Kerns et al., 2007) was unexpected. The type II K6a
and/or K6b are usually cotranscribed with the type I K16 in
adult epithelia and sometimes with K17 as well (McGowan
and Coulombe, 1998a; Smith et al., 1998). Our ﬁnding that
K6a and K6b are not signiﬁcantly induced in Keap1 hypo-
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Figure 3. SF-induced ﬂuctuations in glutathione levels by SF play
a role in keratin induction. (A) Fold-change in total glutathione
levels (mean  SEM from three experiments) measured in female
SKH-1 hairless mouse skin tissue at 2 h after treatment with vehicle
alone (adjusted to 1), SF, or SF combined with GME. (B) Indirect
immunoﬂuorescence for K17 and K16 in skin tissue sections from
SKH-1 mice after three treatments with SF or SF in combination
with GME. (C) Fold-change in total glutathione levels (mean  SEM
from three experiments) measured in female SKH-1 hairless mouse
skin tissue at 24 h after treatment with vehicle alone (adjusted to 1),
SF, or SF combined with BSO. (D) Indirect immunoﬂuorescence for
K16 in skin tissue sections from Nrf2/ mice after three treatments
with SF or SF in combination with GME. In A and C, Student’s t test:
*p  0.05, **p  0.01, ***p  0.001. For B and D, sections were lightly
stained with Hoechst dye to reveal nuclei. Arrows depict the dermo-
epidermal interface. Epi, epidermis; hf, hair follicle. Bars, 100 m.
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2007). At ﬁrst glance, this ﬁnding may appear at odds with
the report that the K6a gene contains a functional ARE and
is robustly induced in the markedly hyperkeratotic esopha-
geal epithelium of Keap1 null mice (Wakabayashi et al.,
2003). This said, SF has been shown to directly inhibit nu-
clear factor B (NF-B; Heiss et al., 2001), a transcription
factor required for K6 gene expression in at least some
settings (alone or in combination for other factors such as
AP-1; see Navarro et al., 1995; Ma et al., 1997). It could be,
therefore, that NF-B inhibition prevents the induction of K6
gene expression after SF treatment. Additional studies are
required to further probe this intriguing phenomenon.
There is microarray-based evidence for SF-induced gene
expression in the absence of Nrf2 in select cell models (Kraft
et al., 2004; Hu et al., 2006), though to our knowledge this has
not been shown for epidermal keratinocytes. The biochem-
ical mechanism(s) involved have not been elucidated. The
ﬁndings reported here bring forth several issues of interest.
For instance, which genes other than K17 are turned on in an
Nrf2-independent manner after keratinocyte exposure to SF
and what is their relevance to the overall response mounted
by the cell? In this regard several intermediate ﬁlaments
genes are rapidly induced whenever the cells and tissues
expressing them are subject to environmental challenges.
For the K6/K16/K17 subgrouping of keratin genes, such ad-
verse conditions include wounding, viral infection, UV ex-
posure, and disease processes that result in aberrant differ-
entiation within stratiﬁed epithelia (Weiss et al., 1984; Stoler
et al., 1988; Jiang et al., 1994; Leigh et al., 1995; Paladini et al.,
1996). In a few cases, the role of the IF protein being induced
has been deﬁned and includes protection against apoptosis
in a signal-speciﬁc manner (see Kim and Coulombe, 2007),
stimulation of protein synthesis and cell growth (Kim et al.,
2006), providing a phosphate sink for hyperactive, stress-
related kinases (Ku and Omary, 2006), and regulation of
reactive oxygen species (ROS)-induced and mitochondria-
mediated death in hepatic cells (Mathew et al., 2008). The
role that K17 might fulﬁll in a cellular context where gluta-
thione levels are low is a question worth pursuing. Another
issue of interest is the relationship between glutathione and
K17 expression. Regulation of the balance between reduced
and oxidized forms of glutathione (GSH/GSSG) in the cell,
Figure 4. Role of MAP kinases in the modu-
lation of keratin expression by SF. (A) Depen-
dence of MAP kinase activation on alteration
of glutathione levels by SF in skin. Mice were
treated with either SF alone or SF in combina-
tion with GME, and the activation status of
MAP kinases in skin was assessed via ELISA.
Data (mean  SEM) are reported as fold
change over treatment with SF alone (adjusted
to unity). (B) Indirect immunoﬂuorescence for
K17 and K16 in skin tissue sections after treat-
ment with SF alone or in combination with
inhibitors to p38 (SF  SB), JNK (SF  SP), or
ERK (SF  UO). (C) Indirect immunoﬂuores-
cence for K16 in Nrf2/ mouse skin after treat-
ment with SF alone, or in combination with in-
hibitors to p38 (SF  SB), JNK (SF  SP), or ERK
(SF  UO). Sections were lightly stained with
Hoechst dye to reveal nuclei. Arrows depict the
dermo-epidermal interface. Epi, epidermis; hf,
hair follicle. Bars, 100 m. Student’s t test: *p 
0.05, **p  0.01, ***p  0.001.
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Figure 5. Model depicting the cascade of signaling events leading
to keratin induction “early” (A) and “late” (B) after treatment of
mouse epidermis with SF. (A) Within 3 h after SF exposure, a
marked decrease in total glutathione levels occurs, coinciding in the
activation of MAP kinases. This culminates in activation of AP-1, a
transcription factor able to activate K17 expression. (B) Later on, SF
can directly stimulate Nrf2 by alleviating its tethering to Keap1 in
the cytoplasm. A portion of K16 induction is directly due to Nrf2
transcriptional activation. In addition, glutathione levels have re-
bounded and exceed normal baseline levels, stimulating MEK and
ERK signaling and leading to AP-1 activation and K16 induction.
See Discussion for details.
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cLeod et al., 2009).
Treatment with SF has been shown to be very effective in
alleviating skin blistering in a mouse model for K14 deﬁ-
ciency, thus showing promise as a therapeutic agent for a
subset of epidermolysis bullosa simplex cases (Kerns et al.,
2007). The list of conditions that stand to beneﬁt from treat-
ment with natural products enriched in this remarkable
molecule (Shapiro et al., 2006; Dinkova-Kostova et al., 2007)
is growing steadily. The ﬁndings reported here shed new
light into the complexity of the cellular pathways that are
impacted by SF and related molecules and as such may
assist in efforts to use them appropriately in a clinical setting.
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